{"id":"W2124443610","doi":"10.1634/theoncologist.10-10-780","title":"Adjuvant Chemotherapy for Early Breast Cancer: Optimal Use of Epirubicin","year":2005,"lang":"en","type":"review","venue":"The Oncologist","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Epirubicin; Medicine; Trastuzumab; Breast cancer; Oncology; Cardiotoxicity; Adjuvant; Anthracycline; Internal medicine; Chemotherapy; Doxorubicin; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004514229,0.000564548,0.001063951,0.001245094,0.0001509669,0.0005805201,0.0005919992,0.0007927669,0.0034729],"category_scores_gemma":[0.0006427845,0.0001728785,0.0002793616,0.001274467,0.0002524634,0.0008110973,0.0002722447,0.001257204,0.002817993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004445425,"about_ca_system_score_gemma":0.0005598587,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000654202,"about_ca_topic_score_gemma":0.001475092,"domain_scores_codex":[0.9998817,0.00002749027,0.00001660347,0.00001550502,0.0000502551,0.000008410854],"domain_scores_gemma":[0.9997935,0.00008962362,0.00004047605,0.000006285273,0.00005408381,0.00001596094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008038228,0.00005996438,0.0001614844,0.006205192,0.00003093241,0.0003358195,0.00002525646,0.0002543631,0.001041215,0.001417105,0.03724286,0.9531454],"study_design_scores_gemma":[0.00004793675,0.0001280588,0.001329875,0.003541726,0.00005785045,0.002861656,0.00004691427,0.0001115836,0.0007581597,0.001318977,0.9897845,0.00001271496],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001797865,0.9965964,0.0002138452,0.0006033439,0.0002581212,0.000007782635,0.00001486555,0.000009708597,0.002116126],"genre_scores_gemma":[0.0009660909,0.997001,0.0002788095,0.0003533338,0.000220262,0.00000967185,0.00002376346,0.000001885798,0.001145176],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0034729,"threshold_uncertainty_score":0.01161802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0729664907286145,"score_gpt":0.3820396497003825,"score_spread":0.309073158971768,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}